Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of FSGS and IgAN on Patients and Caregivers Study (HONUS) - A Multi-National, Cross-Sectional Survey Study

NCT05200871 is registered in ClinicalTrials.gov with Travere Therapeutics, Inc. as lead sponsor.

NCT NCT05200871
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05200871 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Humanistic Burden of Rare Kidney Diseases: Understanding the Impact of FSGS and IgAN on Patients and Caregivers Study (HONUS) - A Multi-National, Cross-Sectional Survey Study
Lead sponsor
Travere Therapeutics, Inc.
Phase
Observational
Overall status
Completed
Start date
February 5, 2022
Completion date
October 31, 2023
Enrollment
487 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

focal segmental glomerulosclerosis, immunoglobulin a nephropathy